Head of Investor Relations
Emcure Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Saurabh Paliwal is recorded as Head of Investor Relations at Emcure Pharmaceuticals Limited. Saurabh Paliwal has spoken on 3 earnings calls across 1 company, most recently for Emcure Pharmaceuticals Limited on November 3, 2026. Emcure Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“I welcome you to MPO's Q2F527 earnings conference call. Thank you for joining us today.”
“Good afternoon, everyone, and welcome to Q1F527, a news conference call of employer pharmaceuticals. We'll begin today's session with opening remarks from the management, followed by Q&A session.”
“Good afternoon, everyone, and welcome to the Q4 F526 earnings conference call for MQR Pharmaceuticals. Thank you for joining us today. I am Saurabh Paliwal, and We'll begin today with brief opening remarks from the management, and then open the line for Q&A after the commentary concludes.”
Emcure Pharmaceuticals Limited
Head of Investor Relations
Transcript header (unverified)
Emcure Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Earnings Call for the Quarter Ended September 30, 2026
Emcure Pharmaceuticals Limited
Earnings Call
Emcure Pharmaceuticals Limited
Earnings Call
Emcure Pharmaceuticals Limited
